Concerns raised after election row over pharmaceuticals in post-Brexit UK-US trade deal
A social justice campaign group has warned that including the pharmaceutical sector in a proposed UK-US trade deal would have major negatives for the research sector.
During election campaigning last week, Labour Party leader Jeremy Corbyn claimed that a leaked UK-US trade dossier proved the National Health Service and the pharmaceutical industry would be part of post-Brexit trade negotiations.
This article is only available to Research Professional News subscribers. If you are a subscriber you can read the article in full on researchprofessional.com
Pivot-RP users can log in and view the article via this link.